Foot Ulcer: Clinical Trials

8 trials for Foot Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Terminated 8

Follow Foot Ulcer: new trials by email Literature Review of Foot Ulcer trials Research Report on Foot Ulcer

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)
Fespixon Cream - Diabetic Foot Ulcer (DFU)
Phase 4TerminatedOneness Biotech Co., Ltd.32022-08-042024-05-16
TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers
TruSkin®, Wound Cover - Diabetic Foot Ulcers
Phase 4TerminatedOsiris Therapeutics142016-07-012017-04-06
RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs
MIST Therapy, SOC - Standard of Care - Diabetic Foot Ulcer
Phase 4TerminatedCelleration, Inc.132012-05-012014-10-08
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Bacitracin, AmeriGel®, Vitamin C - Diabetes, Type 1, Diabetes, Type 2
Phase 4TerminatedSusan Hassenbein22012-02-012017-12-12
Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds
octenisept®, Placebo - Ulcus Cruris
Phase 4TerminatedSchülke & Mayr GmbH92011-10-012014-05-13
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
Cubicin, Vancomycin - Diabetic Foot
Phase 4TerminatedClinical Alliance for Research & Education - Infectious Diseases, LLC.62010-08-012013-09-10
Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
INTEGRA™ Flowable Matrix (Collagen) - Diabetes, Foot Ulcer
Phase 4TerminatedGeorgetown University52010-06-012014-03-17
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
Daptomycin - Staphylococcal Skin Infections
Phase 4TerminatedNovartis522007-01-012011-03-24

Narrower conditions

Diabetic Foot (6)  ·  Abscess (1)  ·  Cellulitis (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Staphylococcal Skin Infections (1)

Broader conditions

Leg Ulcer (8)  ·  Skin Diseases (8)  ·  Skin Ulcer (8)  ·  Skin and Connective Tissue Diseases (8)  ·  Endocrine System Diseases (7)  ·  Cardiovascular Diseases (6)  ·  Diabetes Complications (6)  ·  Diabetes Mellitus (6)  ·  Diabetic Angiopathies (6)  ·  Diabetic Neuropathies (6)  ·  Vascular Diseases (6)  ·  Foot Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)

Interventions

Daptomycin (2)  ·  Ascorbic Acid (1)  ·  Bacitracin (1)  ·  Collagen (1)  ·  Vancomycin (1)  ·  oak bark extract (1)  ·  octenidine and phenoxyethanol drug combination (1)

Sponsors

Celleration, Inc. (1)  ·  Clinical Alliance for Research & Education - Infectious Diseases, LLC. (1)  ·  Georgetown University (1)  ·  Novartis (1)  ·  Oneness Biotech Co., Ltd. (1)  ·  Osiris Therapeutics (1)  ·  Schülke & Mayr GmbH (1)  ·  Susan Hassenbein (1)

Countries

United States (5)  ·  Germany (1)  ·  Italy (1)  ·  Taiwan (1)

Top investigators

Donald Poretz, MD (1)  ·  John Steinberg, DPM (1)  ·  Matthias Augustin, MD (1)  ·  Nell V. Blake, DPM (1)  ·  Shyi-Gen Chen, VP (1)  ·  Vickie Driver, DPM (1)